Simple parameters predicting extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma

Abstract Extrahepatic recurrence (EHR) after curative hepatectomy for hepatocellular carcinoma (HCC) is associated with a poor prognosis. We investigated the features of EHR and identified its predictive factors. This retrospective study included 398 treatment-naive patients who underwent curative h...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jae Hyun Yoon, Won Jae Lee, Sun Min Kim, Kwang Tack Kim, Sung Bum Cho, Hee Joon Kim, Yang Seok Ko, Hyun Yi Kook, Chung Hwan Jun, Sung Kyu Choi, Ban Seok Kim, Seo Yeon Cho, Hye-Su You, Yohan Lee, Seyeong Son
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/aff2aa961e714e1aa60dd4a5ccb3ef18
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:aff2aa961e714e1aa60dd4a5ccb3ef18
record_format dspace
spelling oai:doaj.org-article:aff2aa961e714e1aa60dd4a5ccb3ef182021-12-02T18:02:49ZSimple parameters predicting extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma10.1038/s41598-021-92503-62045-2322https://doaj.org/article/aff2aa961e714e1aa60dd4a5ccb3ef182021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-92503-6https://doaj.org/toc/2045-2322Abstract Extrahepatic recurrence (EHR) after curative hepatectomy for hepatocellular carcinoma (HCC) is associated with a poor prognosis. We investigated the features of EHR and identified its predictive factors. This retrospective study included 398 treatment-naive patients who underwent curative hepatectomy for HCC at two tertiary hospitals. Multivariate Cox-regression analysis was performed to identify the variables associated with EHR. EHR was diagnosed in 94 patients (23.6%) over a median follow-up period of 5.92 years, most commonly in the lungs (42.6%). The 5-/10-year cumulative rates of HCC recurrence and EHR were 63.0%/75.6% and 18.1%/35.0%, respectively. The median time to EHR was 2.06 years. Intrahepatic HCC recurrence was not observed in 38.3% of patients on EHR diagnosis. On multivariate analysis, pathologic modified Union for International Cancer Control stage (III, IVa), surgical margin involvement, tumor necrosis, sum of tumor size > 7 cm, and macrovascular invasion were predictive factors of EHR. Four risk levels and their respective EHR rates were defined as follows: very low risk, 1-/5-year, 3.1%/11.6%; low risk, 1-/5-year, 12.0%/27.7%; intermediate risk, 1-/5-year, 36.3%/60.9%; and high risk, 1-year, 100.0%. Our predictive model clarifies the clinical course of EHR and could improve the follow-up strategy to improve outcomes.Jae Hyun YoonWon Jae LeeSun Min KimKwang Tack KimSung Bum ChoHee Joon KimYang Seok KoHyun Yi KookChung Hwan JunSung Kyu ChoiBan Seok KimSeo Yeon ChoHye-Su YouYohan LeeSeyeong SonNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jae Hyun Yoon
Won Jae Lee
Sun Min Kim
Kwang Tack Kim
Sung Bum Cho
Hee Joon Kim
Yang Seok Ko
Hyun Yi Kook
Chung Hwan Jun
Sung Kyu Choi
Ban Seok Kim
Seo Yeon Cho
Hye-Su You
Yohan Lee
Seyeong Son
Simple parameters predicting extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma
description Abstract Extrahepatic recurrence (EHR) after curative hepatectomy for hepatocellular carcinoma (HCC) is associated with a poor prognosis. We investigated the features of EHR and identified its predictive factors. This retrospective study included 398 treatment-naive patients who underwent curative hepatectomy for HCC at two tertiary hospitals. Multivariate Cox-regression analysis was performed to identify the variables associated with EHR. EHR was diagnosed in 94 patients (23.6%) over a median follow-up period of 5.92 years, most commonly in the lungs (42.6%). The 5-/10-year cumulative rates of HCC recurrence and EHR were 63.0%/75.6% and 18.1%/35.0%, respectively. The median time to EHR was 2.06 years. Intrahepatic HCC recurrence was not observed in 38.3% of patients on EHR diagnosis. On multivariate analysis, pathologic modified Union for International Cancer Control stage (III, IVa), surgical margin involvement, tumor necrosis, sum of tumor size > 7 cm, and macrovascular invasion were predictive factors of EHR. Four risk levels and their respective EHR rates were defined as follows: very low risk, 1-/5-year, 3.1%/11.6%; low risk, 1-/5-year, 12.0%/27.7%; intermediate risk, 1-/5-year, 36.3%/60.9%; and high risk, 1-year, 100.0%. Our predictive model clarifies the clinical course of EHR and could improve the follow-up strategy to improve outcomes.
format article
author Jae Hyun Yoon
Won Jae Lee
Sun Min Kim
Kwang Tack Kim
Sung Bum Cho
Hee Joon Kim
Yang Seok Ko
Hyun Yi Kook
Chung Hwan Jun
Sung Kyu Choi
Ban Seok Kim
Seo Yeon Cho
Hye-Su You
Yohan Lee
Seyeong Son
author_facet Jae Hyun Yoon
Won Jae Lee
Sun Min Kim
Kwang Tack Kim
Sung Bum Cho
Hee Joon Kim
Yang Seok Ko
Hyun Yi Kook
Chung Hwan Jun
Sung Kyu Choi
Ban Seok Kim
Seo Yeon Cho
Hye-Su You
Yohan Lee
Seyeong Son
author_sort Jae Hyun Yoon
title Simple parameters predicting extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma
title_short Simple parameters predicting extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma
title_full Simple parameters predicting extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma
title_fullStr Simple parameters predicting extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma
title_full_unstemmed Simple parameters predicting extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma
title_sort simple parameters predicting extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/aff2aa961e714e1aa60dd4a5ccb3ef18
work_keys_str_mv AT jaehyunyoon simpleparameterspredictingextrahepaticrecurrenceaftercurativehepatectomyforhepatocellularcarcinoma
AT wonjaelee simpleparameterspredictingextrahepaticrecurrenceaftercurativehepatectomyforhepatocellularcarcinoma
AT sunminkim simpleparameterspredictingextrahepaticrecurrenceaftercurativehepatectomyforhepatocellularcarcinoma
AT kwangtackkim simpleparameterspredictingextrahepaticrecurrenceaftercurativehepatectomyforhepatocellularcarcinoma
AT sungbumcho simpleparameterspredictingextrahepaticrecurrenceaftercurativehepatectomyforhepatocellularcarcinoma
AT heejoonkim simpleparameterspredictingextrahepaticrecurrenceaftercurativehepatectomyforhepatocellularcarcinoma
AT yangseokko simpleparameterspredictingextrahepaticrecurrenceaftercurativehepatectomyforhepatocellularcarcinoma
AT hyunyikook simpleparameterspredictingextrahepaticrecurrenceaftercurativehepatectomyforhepatocellularcarcinoma
AT chunghwanjun simpleparameterspredictingextrahepaticrecurrenceaftercurativehepatectomyforhepatocellularcarcinoma
AT sungkyuchoi simpleparameterspredictingextrahepaticrecurrenceaftercurativehepatectomyforhepatocellularcarcinoma
AT banseokkim simpleparameterspredictingextrahepaticrecurrenceaftercurativehepatectomyforhepatocellularcarcinoma
AT seoyeoncho simpleparameterspredictingextrahepaticrecurrenceaftercurativehepatectomyforhepatocellularcarcinoma
AT hyesuyou simpleparameterspredictingextrahepaticrecurrenceaftercurativehepatectomyforhepatocellularcarcinoma
AT yohanlee simpleparameterspredictingextrahepaticrecurrenceaftercurativehepatectomyforhepatocellularcarcinoma
AT seyeongson simpleparameterspredictingextrahepaticrecurrenceaftercurativehepatectomyforhepatocellularcarcinoma
_version_ 1718378889882894336